Literature DB >> 19270518

Genomic instability en route to and from cancer stem cells.

Linda Li1, Laura Borodyansky, Youxin Yang.   

Abstract

Cancer is caused by successive gene mutations that amount to confer malignant phenotype. Genomic instability (GIN) is considered a key endogenous mechanism for accumulation of mutations, and therefore, has been proposed as an engine of tumorigenesis. Recently, cancer stem cells, or tumor initiating cells, have been identified in a variety of human cancers. These cancer stem cells (CSCs) are believed to be responsible for the initiation of malignant growth and metastasis of some, and perhaps all cancer types. How are these two engines of tumorigenesis related to each other? Is GIN a driving force in the genesis of cancer stem cells? Is the genome in CSCs inherently unstable? Could GIN in CSCs be the cause of the observed cancer cell heterogeneity? In this article, we will discuss some early clues indicating that these two driving forces of tumorigenesis appear to be intimately connected.

Entities:  

Mesh:

Year:  2009        PMID: 19270518     DOI: 10.4161/cc.8.7.8041

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  17 in total

1.  Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors.

Authors:  Matthew I Confeld; Babak Mamnoon; Li Feng; Heather Jensen-Smith; Priyanka Ray; James Froberg; Jiha Kim; Michael A Hollingsworth; Mohiuddin Quadir; Yongki Choi; Sanku Mallik
Journal:  Mol Pharm       Date:  2020-07-22       Impact factor: 4.939

Review 2.  Development of cancer-initiating cells and immortalized cells with genomic instability.

Authors:  Ken-Ichi Yoshioka; Yuko Atsumi; Hitoshi Nakagama; Hirobumi Teraoka
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Therapies targeting cancer stem cells: Current trends and future challenges.

Authors:  Denisa L Dragu; Laura G Necula; Coralia Bleotu; Carmen C Diaconu; Mihaela Chivu-Economescu
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

4.  Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Authors:  Stephen L Abrams; Linda S Steelman; John G Shelton; William Chappell; Jörg Bäsecke; Franca Stivala; Marco Donia; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; James A McCubrey
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

5.  The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy.

Authors:  Stephen L Abrams; Linda S Steelman; John G Shelton; Ellis W T Wong; William H Chappell; Jörg Bäsecke; Franca Stivala; Marco Donia; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; James A McCubrey
Journal:  Cell Cycle       Date:  2010-05-10       Impact factor: 4.534

6.  Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs.

Authors:  Linda S Steelman; Stephen L Abrams; John G Shelton; William H Chappell; Jörg Bäsecke; Franca Stivala; Marco Donia; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; James A McCubrey
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

7.  CXCR4 positive cells from Lewis lung carcinoma cell line have cancer metastatic stem cell characteristics.

Authors:  Wei-Qi Nian; Fang-Lin Chen; Xu-Jun Ao; Zheng-Tang Chen
Journal:  Mol Cell Biochem       Date:  2011-05-07       Impact factor: 3.396

Review 8.  New insights into pancreatic cancer stem cells.

Authors:  Chinthalapally V Rao; Altaf Mohammed
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 9.  Natural Products That Target Cancer Stem Cells.

Authors:  Jim Moselhy; Sowmyalakshmi Srinivasan; Murali K Ankem; Chendil Damodaran
Journal:  Anticancer Res       Date:  2015-11       Impact factor: 2.480

10.  Stem-like cancer cells are inducible by increasing genomic instability in cancer cells.

Authors:  Yi Liang; Zhendong Zhong; Yijun Huang; Wen Deng; Junxia Cao; George Tsao; Quentin Liu; Duanqing Pei; Tiebang Kang; Yi-Xin Zeng
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.